1. Guideline for Submitting Supporting Documentation in Drug Applications for the Manufacture of Drug Substances, Office of Drug Evaluation and Research, Food and Drug Administration, Washington, DC, 1987, p. 3; S.C. Stinton, Chem. Eng. News, (28 September 1992) 46.
2. P. Bravo, G. Resnati, Tetrahedron: Asymmetry 1 (1990) 661; G. Resnati, Tetrahedron 49 (1993) 9385.
3. P. Bravo, E. Piovosi, G. Resnati, Synthesis (1986) 579; A. Arnone, P. Bravo, M. Frigerio, G. Salani, F. Viani, C. Zappalà, G. Cavicchio, M. Crucianelli, Tetrahedron 51 (1995) 8289 and references therein.
4. For recent reviews see R.E. Banks, J.C. Tatlow, B.E. Smart, Organofluorine Chemistry: Principles and Commercial Applications, Plenum, New York, 1994; G. Resnati, V.A. Soloshonok (Eds.), Fluoroorganic Chemistry: Synthetic Challenges and Biomedical Rewards; Tetrahedron Symposium-in-Print N. 58, Tetrahedron 52 (1996) 1–330.
5. J.R. McCarthy, N.P. Peet, M.E. Le Tourneau, M. Inbasekaran, J. Am. Chem. Soc. 107 (1985) 735. M. Robins, S.F. Wnuk, J. Org. Chem. 55 (1990) 4757; P. Herdewijn, A. De Bruyn, P. Wigerinck, C. Hendrix, L. Kerremans, J. Rozenski, R. Busson, J. Chem. Soc. Perkin Trans. I (1994) 249; L.S. Jeong, V.E. Marquez, Chem. Lett. (1995) 301. For other fluorinations of sulfoxides see M.J. Robins, S.F. Wnuk, K.B. Mullah, N.K. Dalley, C.-S. Yuan, Y. Lee, R.T. Borchardt, J. Org. Chem. 59 (1994) 544; J. Chiba, T. Sugihara, C. Kaneko, Chem. Lett. (1995) 581.